Previsioni di mercato degli isolatori farmaceutici per l\'Asia Pacifico fino al 2028 - Impatto del COVID-19 e analisi regionale per tipologia (isolatore aperto e isolatore chiuso), pressione (pressione positiva e pressione negativa), configurazione (a pavimento, modulare, mobile e compatto), applicazione ( Isolatori asettici, isolatori di contenimento, isolatori di campionamento e pesatura, isolatori di erogazione di fluidi e altri) e utente finale (ospedali, aziende farmaceutiche e biotecnologiche, laboratori accademici e di ricerca e altri)

Introduzione al mercato

Il mercato degli isolatori farmaceutici dell\'area APAC è suddiviso in cinque paesi principali: Cina, Giappone, India, Australia, Corea del Sud e il resto dell\'APAC. Il mercato nella regione è in gran parte detenuto da paesi come Cina e Giappone. Nell\'Asia del Pacifico, la Cina è il mercato più grande per il mercato degli isolatori farmaceutici biofarmaceutici. La crescita del mercato è attribuita principalmente al mercato farmaceutico consolidato, all’aumento delle spese di ricerca e sviluppo da parte delle aziende farmaceutiche e biofarmaceutiche e alle politiche normative favorevoli. La Cina ha il secondo mercato farmaceutico più grande del mondo. L’eccessiva popolazione in Cina, insieme all’aumento di varie malattie trasmissibili e non trasmissibili, stanno guidando principalmente la crescita delle aziende farmaceutiche in Cina e rendendola un mercato primario nella regione dell’Asia del Pacifico. Ad esempio, lo scoppio del Coronavirus in Cina ha portato al lancio di diversi farmaci per contrastare il coronavirus (Covid-19). Ha aumentato la produzione a contratto nel paese, portando alla crescita del mercato. La crescente adozione dell\'automazione negli isolatori farmaceutici e l\'incremento delle industrie farmaceutiche e biotecnologiche sono il fattore principale che guida la crescita del mercato degli isolatori farmaceutici nell\'area APAC

In caso di COVID-19, l\'area APAC è fortemente colpita, in particolare l\'India. L’industria biofarmaceutica dell’area APAC è stata turbata per alcuni mesi del 2020 dallo scoppio della pandemia di COVID-19. Tuttavia, con la crescente domanda di prodotti per il trattamento dell’infezione da COVID-19, le aziende biofarmaceutiche e farmaceutiche di paesi come India e Cina hanno aumentato la loro produzione di API poiché questi paesi sono i maggiori esportatori verso le aziende occidentali. Ad esempio, Wockhardt Ltd è in trattative con il governo indiano per offrire la sua struttura di sviluppo sterile per i vaccini covid-19 che saranno sviluppati nel paese, nonché con alcune aziende i cui vaccini sono attualmente in fase di sperimentazione di fase I/II a livello globale. Inoltre, il 7 maggio 2020, Ajinomoto Bio-Pharma Services, fornitore leader di servizi di sviluppo e produzione a contratto biofarmaceutici con siti in Belgio, Stati Uniti, Giappone e India, ha annunciato di aver stipulato un accordo di servizi di produzione con CytoDyn Inc., una società di biotecnologie in fase avanzata, per la fornitura del nuovo farmaco sperimentale, leronlimab (PRO 140), attualmente utilizzato nei protocolli di sperimentazione clinica per pazienti affetti da COVID-19 da lievi a moderati e gravemente malati. I paesi stanno registrando una crescita anche nella produzione di prodotti biologici; cresce la produzione conto terzi di prodotti biofarmaceutici e farmaceutici. Ad esempio, nel gennaio 2020, STA Pharmaceutical Co., Ltd. (WuXi AppTec) ha ampliato la propria produzione di API oligonucleotidi in Cina. Allo stesso modo, le aziende si sono impegnate nella produzione di vaccini e li hanno inviati a studi clinici. Ad esempio, in Giappone, Remdesivier di Gilead e Avigan antivirale di Fujifilm sono in fase III di sperimentazione clinica. Pertanto, con la crescente produzione da parte dell\'industria biofarmaceutica, è probabile che il mercato degli isolatori farmaceutici abbia opportunità di crescita vitali negli anni successivi.

Panoramica e dinamiche del mercato

Si prevede che il mercato degli isolatori farmaceutici nella regione APAC crescerà da 1.060,82 milioni di dollari nel 2021 a 1.975,83 milioni di dollari entro il 2028; si stima che crescerà a un CAGR del 9,3% dal 2021 al 2028. Diverse aziende farmaceutiche grandi e piccole sono impegnate nello sviluppo e nella produzione di molecole nuove e innovative per condizioni potenzialmente letali. I sistemi di isolamento farmaceutico sono stati considerati una tecnologia chiave nel processo di scoperta dei farmaci. Pertanto, l’adozione di isolatori farmaceutici è in aumento per garantire una produzione e una manipolazione dei prodotti prive di contaminazioni. L\'isolatore farmaceutico garantisce sicurezza all\'operatore dall\'esposizione a farmaci dannosi, elimina le possibilità di contaminazione incrociata e mantiene lo standard di qualità del farmaco. Nell\'industria farmaceutica è estremamente importante mantenere la massima cautela durante il processo di fabbricazione del prodotto. Nel mercato farmaceutico sono disponibili diversi tipi di isolatori che forniscono un livello ottimale di sterilità nel processo di fabbricazione del prodotto. La manipolazione di prodotti farmaceutici con ingredienti ad alta potenza, come ormoni e antibiotici. I farmaci biologici necessitano di un livello maggiore di precauzioni. Negli ultimi dieci anni le aziende farmaceutiche e biotecnologiche hanno investito sostanzialmente nelle tecniche di isolamento farmaceutico. I crescenti investimenti da parte delle aziende farmaceutiche e biotecnologiche e le vaste pipeline di farmaci per il trattamento di varie malattie croniche, come il cancro, i disturbi cardiovascolari, i disturbi metabolici, i disturbi immunologici e i disturbi neurologici, sono i principali motori della crescita del mercato degli isolatori farmaceutici dell’APAC.

Segmenti chiave del mercato

In termini di tipologia, il segmento degli isolatori aperti rappresentava la quota maggiore degli isolatori farmaceutici dell\'area APAC nel 2020. In termini di pressione, il segmento della pressione positiva ha detenuto una quota di mercato maggiore del mercato degli isolatori farmaceutici dell’APAC nel 2020. In termini di configurazione, il segmento da pavimento ha detenuto una quota di mercato maggiore del mercato degli isolatori farmaceutici dell’APAC nel 2020. In termini di applicazione, nel 2020 il segmento degli isolatori asettici ha detenuto una quota di mercato maggiore del mercato degli isolatori farmaceutici dell\'APAC. Inoltre, nel 2020 il segmento delle aziende farmaceutiche e biotecnologiche ha detenuto una quota maggiore del mercato degli isolatori farmaceutici dell\'APAC in base all\'utente finale.

Principali fonti e società elencate

Alcune delle principali fonti primarie e secondarie citate per la preparazione di questo rapporto sul Il mercato degli isolatori farmaceutici dell\'APAC comprende siti Web aziendali, relazioni annuali, relazioni finanziarie, documenti governativi nazionali e database statistici, tra gli altri. Le principali aziende elencate nel rapporto sono Azbil Telstar, Bioquell (Ecolab Solution), Comecer, Fedegari Autoclavi SpA, Gelman Singapore, Getinge AB, Hosokawa Micron Group, Nuaire Inc. e Schematic Engineering Industries.

Rapporto sui motivi per acquistare

Per comprendere il Panorama del mercato degli isolatori farmaceutici dell\'area APAC e identificare i segmenti di mercato che hanno maggiori probabilità di garantire un forte rendimento
Stai al passo con la corsa comprendendo il panorama competitivo in continua evoluzione per il mercato degli isolatori farmaceutici dell\'area APAC
Pianificare in modo efficiente operazioni di fusione e acquisizione e accordi di partnership nel mercato degli isolatori farmaceutici dell\'APAC identificando i segmenti di mercato con le vendite probabili più promettenti
Aiuta a prendere decisioni aziendali consapevoli attraverso un\'analisi percettiva e completa delle prestazioni di mercato di vari segmenti farmaceutici dell\'APAC mercato degli isolatori
Ottieni previsioni sulle entrate del mercato per vari segmenti dal 2021 al 2028 nella regione APAC.

Segmentazione del mercato degli isolatori farmaceutici nell\'area APAC

Mercato degli isolatori farmaceutici nell\'area APAC - per tipo

Isolatori aperti
Isolatori chiusi

Mercato degli isolatori farmaceutici nell\'area APAC - Per pressione

Pressione positiva
Pressione negativa

Mercato degli isolatori farmaceutici APAC - Per configurazione

Da pavimento
Modulare
Compatto
Mobile

Mercato degli isolatori farmaceutici nella regione APAC - Per applicazione

Asettico
Campionamento & Pesatura
Erogazione di liquidi
Contenimento
Altro

Mercato degli isolatori farmaceutici dell\'area APAC: Per utente finale

Aziende farmaceutiche e biotecnologiche
Ospedali
Laboratori accademici e di ricerca
Altro

Mercato degli isolatori farmaceutici nell\'area APAC: per paese

Mercato degli isolatori farmaceutici nell\'area APAC - Profili aziendali

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 APAC Pharmaceutical Isolator Market – By Type

1.3.2 APAC Pharmaceutical Isolator Market – By Pressure

1.3.3 APAC Pharmaceutical Isolator Market – By Configuration

1.3.4 APAC Pharmaceutical Isolator Market – By Application

1.3.5 APAC Pharmaceutical Isolator Market – By End User

1.3.6 APAC Pharmaceutical Isolator Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Market Landscape

4.1 Overview

4.2 APAC PEST Analysis

4.3 Experts Opinion

5. APAC Pharmaceutical Isolator Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Surging investments by Pharmaceutical and Biotechnology Industry

5.1.2 Structure to Support Adoption of Pharmaceutical Isolators

5.2 Market Restraint

5.2.1 Overpriced Operation and Maintenance

5.3 Market Opportunities

5.3.1 Escalating Pharmaceutical and Biotechnological Industries

5.4 Future Trends

5.4.1 Burgeoning Adoption of Automation in Pharmaceutical Isolator

5.5 Impact Analysis

6. Pharmaceutical Isolator Market – APAC Analysis

6.1 APAC Pharmaceutical Isolator Market Revenue Forecast and Analysis

7. APAC Pharmaceutical Isolator Market Analysis and forecasts to 2028 –By Type

7.1 Overview

7.2 APAC Pharmaceutical Isolator Market Share by Type 2021 & 2028 (%)

7.3 Open Isolator

7.3.1 Overview

7.3.2 Open Isolator Market Revenue and Forecast to 2028 (US$ Mn)

7.4 Closed Isolator

7.4.1 Overview

7.4.2 Closed Isolator Market Revenue and Forecast to 2028 (US$ Mn)

8. APAC Pharmaceutical Isolator Market Analysis and Forecasts to 2028 –By Pressure

8.1 Overview

8.2 APAC Pharmaceutical Isolator Market Share by Pressure 2021 & 2028 (%)

8.3 Positive Pressure

8.3.1 Overview

8.3.2 Positive Pressure Market Revenue and Forecast to 2028 (US$ Mn)

8.4 Negative Pressure

8.4.1 Overview

8.4.2 Negative Pressure Market Revenue and Forecast to 2028 (US$ Mn)

9. APAC Pharmaceutical Isolator Market Analysis and Forecasts to 2028 –By Configuration

9.1 Overview

9.2 APAC Pharmaceutical Isolator Market Share by Configuration 2021 & 2028 (%)

9.3 Floor Standing

9.3.1 Overview

9.3.2 Floor Standing Market Revenue and Forecast to 2028 (US$ Mn)

9.4 Modular

9.4.1 Overview

9.4.2 Modular Market Revenue and Forecast to 2028 (US$ Mn)

9.5 Compact

9.5.1 Overview

9.5.2 Compact Market Revenue and Forecast to 2028 (US$ Mn)

9.6 Mobile

9.6.1 Overview

9.6.2 Mobile Market Revenue and Forecast to 2028 (US$ Mn)

10. APAC Pharmaceutical Isolator Market Analysis and Forecasts to 2028 –By Application

10.1 Overview

10.2 APAC Pharmaceutical Isolator Market Share by Application 2021 & 2028 (%)

10.3 Aseptic Isolators

10.3.1 Overview

10.3.2 Aseptic Isolators Market Revenue and Forecast to 2028 (US$ Mn)

10.4 Sampling and Weighing Isolators

10.4.1 Overview

10.4.2 Sampling and Weighing Isolators Market Revenue and Forecast to 2028 (US$ Mn)

10.5 Fluid Dispensing Isolators

10.5.1 Overview

10.5.2 Fluid Dispensing Isolators Market Revenue and Forecast to 2028 (US$ Mn)

10.6 Containment Isolators

10.6.1 Overview

10.6.2 Containment Isolators Market Revenue and Forecast to 2028 (US$ Mn)

10.7 Others

10.7.1 Overview

10.7.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

11. APAC Pharmaceutical Isolator Market Analysis and Forecasts to 2028 –By End User

11.1 Overview

11.2 APAC Pharmaceutical Isolator Market Share by End User 2021 & 2028 (%)

11.3 Pharmaceuticals and Biotechnology Companies

11.3.1 Overview

11.3.2 Pharmaceutical And Biotechnology Market Revenue and Forecast to 2028 (US$ Mn)

11.4 Hospitals

11.4.1 Overview

11.4.2 Hospitals Market Revenue and Forecast to 2028 (US$ Mn)

11.5 Research and Academic Laboratories

11.5.1 Overview

11.5.2 Research and Academic Laboratories Market Revenue and Forecast to 2028 (US$ Mn)

11.6 Others

11.6.1 Overview

11.6.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

12. APAC Pharmaceutical Isolator Market – Country Analysis

12.1 APAC: Pharmaceutical Isolator Market

12.1.1 Overview

12.1.2 APAC: Pharmaceutical Isolator Market, by Country, 2021 & 2028 (%)

12.1.2.1 China: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.1.1 China: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.1.2 China: Pharmaceutical Isolator Market , by Type – Revenue and Forecast to 2028 (USD Million)

12.1.2.1.3 China: Pharmaceutical Isolator Market , by Pressure – Revenue and Forecast to 2028 (USD Million)

12.1.2.1.4 China: Pharmaceutical Isolator Market , by Configuration – Revenue and Forecast to 2028 (USD Million)

12.1.2.1.5 China: Pharmaceutical Isolator Market , by Application– Revenue and Forecast to 2028 (USD Million)

12.1.2.1.6 China: Pharmaceutical Isolator Market , by End User – Revenue and Forecast to 2028 (USD Million)

12.1.2.2 Japan: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.2.1 Japan: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.2.2 Japan: Pharmaceutical Isolator Market , by Type – Revenue and Forecast to 2028 (USD Million)

12.1.2.2.3 Japan: Pharmaceutical Isolator Market , by Pressure – Revenue and Forecast to 2028 (USD Million)

12.1.2.2.4 Japan: Pharmaceutical Isolator Market , by Configuration – Revenue and Forecast to 2028 (USD Million)

12.1.2.2.5 Japan: Pharmaceutical Isolator Market , by Application– Revenue and Forecast to 2028 (USD Million)

12.1.2.2.6 Japan: Pharmaceutical Isolator Market , by End User – Revenue and Forecast to 2028 (USD Million)

12.1.2.3 India: Pharmaceutical Isolator Market - Revenue and Forecasts to 2028 (USD Million)

12.1.2.3.1 India: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.3.2 India: Pharmaceutical Isolator Market , by Type – Revenue and Forecast to 2028 (USD Million)

12.1.2.3.3 India: Pharmaceutical Isolator Market , by Pressure – Revenue and Forecast to 2028 (USD Million)

12.1.2.3.4 India: Pharmaceutical Isolator Market , by Configuration – Revenue and Forecast to 2028 (USD Million)

12.1.2.3.5 India: Pharmaceutical Isolator Market , by Application– Revenue and Forecast to 2028 (USD Million)

12.1.2.3.6 India: Pharmaceutical Isolator Market , by End User – Revenue and Forecast to 2028 (USD Million)

12.1.2.4 South Korea: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.4.1 South Korea: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.4.2 South Korea: Pharmaceutical Isolator Market , by Type – Revenue and Forecast to 2028 (USD Million)

12.1.2.4.3 South Korea: Pharmaceutical Isolator Market , by Pressure – Revenue and Forecast to 2028 (USD Million)

12.1.2.4.4 South Korea: Pharmaceutical Isolator Market , by Configuration – Revenue and Forecast to 2028 (USD Million)

12.1.2.4.5 South Korea: Pharmaceutical Isolator Market , by Application– Revenue and Forecast to 2028 (USD Million)

12.1.2.4.6 South Korea: Pharmaceutical Isolator Market , by End User – Revenue and Forecast to 2028 (USD Million)

12.1.2.5 Australia: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.5.1 Australia: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.5.2 Australia: Pharmaceutical Isolator Market , by Type – Revenue and Forecast to 2028 (USD Million)

12.1.2.5.3 Australia: Pharmaceutical Isolator Market , by Pressure – Revenue and Forecast to 2028 (USD Million)

12.1.2.5.4 Australia: Pharmaceutical Isolator Market , by Configuration – Revenue and Forecast to 2028 (USD Million)

12.1.2.5.5 Australia: Pharmaceutical Isolator Market , by Application – Revenue and Forecast to 2028 (USD Million)

12.1.2.5.6 Australia: Pharmaceutical Isolator Market , by End User – Revenue and Forecast to 2028 (USD Million)

12.1.2.6 Rest of APAC: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.6.1 Rest of APAC: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.6.2 Rest of APAC: Pharmaceutical Isolator Market , by Type – Revenue and Forecast to 2028 (USD Million)

12.1.2.6.3 Rest of APAC: Pharmaceutical Isolator Market , by Pressure – Revenue and Forecast to 2028 (USD Million)

12.1.2.6.4 Rest of APAC: Pharmaceutical Isolator Market , by Configuration – Revenue and Forecast to 2028 (USD Million)

12.1.2.6.5 Rest of APAC: Pharmaceutical Isolator Market , by Application– Revenue and Forecast to 2028 (USD Million)

12.1.2.6.6 Rest of APAC: Pharmaceutical Isolator Market , by End User – Revenue and Forecast to 2028 (USD Million)

13. Impact of COVID-19 Pandemic on APAC Pharmaceutical Isolator Market

13.1 APAC: Impact Assessment of COVID-19 Pandemic

14. Industry Landscape

14.1 Overview

14.2 Organic Developments

14.2.1 Overview

14.3 Inorganic Developments

14.3.1 Overview

15. Company Profiles

15.1 Schematic Engineering Industries

15.1.1 Key Facts

15.1.2 Business Description

15.1.3 Products and Services

15.1.4 Financial Overview

15.1.5 SWOT Analysis

15.1.6 Key Developments

15.2 Nuaire Inc.

15.2.1 Key Facts

15.2.2 Business Description

15.2.3 Products and Services

15.2.4 Financial Overview

15.2.5 SWOT Analysis

15.2.6 Key Developments

15.3 Comecer

15.3.1 Key Facts

15.3.2 Business Description

15.3.3 Products and Services

15.3.4 Financial Overview

15.3.5 SWOT Analysis

15.3.6 Key Developments

15.4 Getinge AB

15.4.1 Key Facts

15.4.2 Business Description

15.4.3 Products and Services

15.4.4 Financial Overview

15.4.5

15.4.6 SWOT Analysis

15.4.7 Key Developments

15.5 Hosokawa Micron Group

15.5.1 Key Facts

15.5.2 Business Description

15.5.3 Products and Services

15.5.4 Financial Overview

15.5.5 SWOT Analysis

15.5.6 Key Developments

15.6 Fedegari Autoclavi S.p.A.

15.6.1 Key Facts

15.6.2 Business Description

15.6.3 Products and Services

15.6.4 Financial Overview

15.6.5 SWOT Analysis

15.6.6 Key Developments

15.7 Azbil Telstar

15.7.1 Key Facts

15.7.2 Business Description

15.7.3 Products and Services

15.7.4 Financial Overview

15.7.5 SWOT Analysis

15.7.6 Key Developments

15.8 Gelman Singapore

15.8.1 Key Facts

15.8.2 Business Description

15.8.3 Products and Services

15.8.4 Financial Overview

15.8.5 SWOT Analysis

15.8.6 Key Developments

15.9 Bioquell ( Ecolab Solution)

15.9.1 Key Facts

15.9.2 Business Description

15.9.3 Products and Services

15.9.4 Financial Overview

15.9.5 SWOT Analysis

15.9.6 Key Developments

16. Appendix

16.1 About The Insight Partners

16.2 Glossary of Terms

LIST OF TABLES

Table 1. APAC Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)

Table 2. China Pharmaceutical Isolator Market , by Type – Revenue and Forecast to 2028 (USD Million)

Table 3. China Pharmaceutical Isolator Market , by Pressure – Revenue and Forecast to 2028 (USD Million)

Table 4. China Pharmaceutical Isolator Market , by Configuration – Revenue and Forecast to 2028 (USD Million)

Table 5. China Pharmaceutical Isolator Market , by Application – Revenue and Forecast to 2028 (USD Million)

Table 6. China Pharmaceutical Isolator Market , by End User – Revenue and Forecast to 2028 (USD Million)

Table 7. Japan Pharmaceutical Isolator Market , by Type – Revenue and Forecast to 2028 (USD Million)

Table 8. Japan Pharmaceutical Isolator Market , by Pressure – Revenue and Forecast to 2028 (USD Million)

Table 9. Japan Pharmaceutical Isolator Market , by Configuration – Revenue and Forecast to 2028 (USD Million)

Table 10. Japan Pharmaceutical Isolator Market , by Application, – Revenue and Forecast to 2028 (USD Million)

Table 11. Japan Pharmaceutical Isolator Market , by End User – Revenue and Forecast to 2028 (USD Million)

Table 12. India: R&D spending of Pharmaceutical companies (2010 & 2017)

Table 13. India Pharmaceutical Isolator Market , by Type – Revenue and Forecast to 2028 (USD Million)

Table 14. India Pharmaceutical Isolator Market , by Pressure – Revenue and Forecast to 2028 (USD Million)

Table 15. India Pharmaceutical Isolator Market , by Configuration – Revenue and Forecast to 2028 (USD Million)

Table 16. India Pharmaceutical Isolator Market , by Application – Revenue and Forecast to 2028 (USD Million)

Table 17. India Pharmaceutical Isolator Market , by End User – Revenue and Forecast to 2028 (USD Million)

Table 18. South Korea Pharmaceutical Isolator Market , by Type – Revenue and Forecast to 2028 (USD Million)

Table 19. South Korea Pharmaceutical Isolator Market , by Pressure – Revenue and Forecast to 2028 (USD Million)

Table 20. South Korea Pharmaceutical Isolator Market , by Configuration– Revenue and Forecast to 2028 (USD Million)

Table 21. South Korea Pharmaceutical Isolator Market , by Application – Revenue and Forecast to 2028 (USD Million)

Table 22. South Korea Pharmaceutical Isolator Market , by End User – Revenue and Forecast to 2028 (USD Million)

Table 23. Australia Pharmaceutical Isolator Market , by Type – Revenue and Forecast to 2028 (USD Million)

Table 24. Australia Pharmaceutical Isolator Market , by Pressure – Revenue and Forecast to 2028 (USD Million)

Table 25. Australia Pharmaceutical Isolator Market , by Configuration – Revenue and Forecast to 2028 (USD Million)

Table 26. Australia Pharmaceutical Isolator Market , by Application – Revenue and Forecast to 2028 (USD Million)

Table 27. Australia Pharmaceutical Isolator Market , by End User – Revenue and Forecast to 2028 (USD Million)

Table 28. Rest of APAC Pharmaceutical Isolator Market , by Type – Revenue and Forecast to 2028 (USD Million)

Table 29. Rest of APAC Pharmaceutical Isolator Market , by Pressure – Revenue and Forecast to 2028 (USD Million)

Table 30. Rest of APAC Pharmaceutical Isolator Market , by configuration – Revenue and Forecast to 2028 (USD Million)

Table 31. Rest of APAC Pharmaceutical Isolator Market , by Application – Revenue and Forecast to 2028 (USD Million)

Table 32. Rest of APAC Pharmaceutical Isolator Market , by End User – Revenue and Forecast to 2028 (USD Million)

Table 33. Organic Developments Done By Companies

Table 34. Inorganic Developments Done by Companies

Table 35. Glossary of Terms

LIST OF FIGURES

Figure 1. APAC Pharmaceutical Isolator Market Segmentation

Figure 2. APAC Pharmaceutical Isolator Market Segmentation, By Country

Figure 3. APAC Pharmaceutical Isolator Market Overview

Figure 4. Open Isolators Segment led the Market in 2021

Figure 5. India to Show Significant Growth During Forecast Period

Figure 6. APAC PEST Analysis

Figure 7. APAC Pharmaceutical Isolator Market Impact Analysis of Driver and Restraints

Figure 8. APAC Pharmaceutical Isolator Market – Revenue Forecast and Analysis

Figure 9. APAC Pharmaceutical Isolator Market Share by Type 2021 & 2028 (%)

Figure 10. APAC Open Isolator Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 11. APAC Closed Isolator Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12. APAC Pharmaceutical Isolator Market Share by Pressure 2021 & 2028 (%)

Figure 13. APAC Positive Pressure Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14. APAC Negative Pressure Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 15. APAC Pharmaceutical Isolator Market Share by Configuration 2021 & 2028 (%)

Figure 16. APAC Floor Standing Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17. APAC Modular Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 18. APAC Compact Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 19. APAC Mobile Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 20. APAC Pharmaceutical Isolator Market Share by Application 2021 & 2028 (%)

Figure 21. APAC Aseptic Isolators Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 22. APAC Sampling and Weighing Isolators Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 23. APAC Fluid Dispensing Isolators Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 24. APAC Containment Isolators Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 25. APAC Others Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 26. APAC Pharmaceutical Isolator Market Share by End User 2021 & 2028 (%)

Figure 27. APAC Pharmaceutical and Biotechnology Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 28. APAC Hospitals Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 29. APAC Research and Academic Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 30. APAC Others Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 31. APAC: Pharmaceutical Isolator Market, by Key Country – Revenue (2021) (USD Million)

Figure 32. APAC: Pharmaceutical Isolator Market, by Country, 2021 & 2028 (%)

Figure 33. China Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)

Figure 34. Japan: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)

Figure 35. India: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)

Figure 36. South Korea: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)

Figure 37. Australia: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)

Figure 38. Rest of APAC: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)

Figure 39. Impact of COVID-19 Pandemic in APAC Country Markets

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the APAC pharmaceutical isolator market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in APAC pharmaceutical isolator market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the pharmaceutical isolator market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Asia Pacific Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software an..	May 2022
Asia Pacific Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Elec..	May 2022
Asia Pacific Ground Engaging Tools Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application (Excavators, Loaders, Bulldozers, an..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample